TuHURA Biosciences (HURA) EBITDA (2010 - 2026)
TuHURA Biosciences (HURA) EBITDA from Sep 30, 2010 to Mar 31, 2026. The TTM TuHURA Biosciences (HURA) EBITDA is -$30M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
TuHURA Biosciences (HURA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +54.66% |
| 3 Years TTM | +21.82% |
| 5 Years TTM | -3.11% |
| 10 Years TTM | +30.42% |
Annual EBITDA change of TuHURA Biosciences (HURA)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$7.49M | -74.48% |
| 2025 | -$29M | +68.48% |
| 2024 | -$17M | -40.18% |
| 2023 | -$29M | +28.85% |
| 2022 | -$23M | -40.90% |
| 2021 | -$38M | +318.84% |
| 2020 | -$9.13M | +13.42% |
| 2019 | -$8.05M | -172.26% |
| 2018 | $11M | +37.87% |
| 2017 | $8.08M | -8.80% |
| 2016 | $8.86M | -303.68% |
| 2015 | -$4.35M | -168.50% |
| 2014 | $6.35M | -176.69% |
| 2013 | -$8.28M | +41300.00% |
| 2012 | -$20K | +100.00% |
| 2011 | -$10K | -50.00% |
| 2010 | -$20K | N/A |
Comparison TuHURA Biosciences (HURA) five years EBITDA CAGR with competitors
TuHURA Biosciences (HURA) five years EBITDA CAGR is -3.12%.